Quoin Pharmaceuticals (QNRX) Other Non-Current Assets (2021 - 2024)
Quoin Pharmaceuticals (QNRX) posted Other Non-Current Assets of $300000.0 for Q4 2024, down 21.75% sequentially from $383390.0 in Q3 2024, and little changed YoY from $300000.0 in Q1 2024.
Quoin Pharmaceuticals (QNRX) Other Non-Current Assets (2021 - 2024) Analysis & Trends
Quoin Pharmaceuticals has reported Other Non-Current Assets for 4 years, with the latest figure at $300000.0 in Q4 2024.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $300000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $300000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $300000.0, changed 0.0% from the prior year.
- Other Non-Current Assets declined to $300000.0 in Q4 2024 per QNRX's latest filing, from $383390.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $383390.0 in Q4 2022 and troughed at $50000.0 in Q2 2022.
- A 4-year average of $307596.4 and a median of $300000.0 in 2021 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 666.78% in 2023, down 21.75% in 2023.
- Over 4 years, Other Non-Current Assets stood at $300000.0 in 2021, then rose by 27.8% to $383390.0 in 2022, then retreated by 21.75% to $300000.0 in 2023, then changed by 0.0% to $300000.0 in 2024.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $300000.0, $383390.0, and $300000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 383,390.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 383,390.00 |
| Mar 31, 2023 | 383,390.00 |
| Dec 31, 2022 | 383,390.00 |
| Jun 30, 2022 | 50,000.00 |
| Dec 31, 2021 | 300,000.00 |